DR. REDDYS LABORATORIES LTD.

NSE : DRREDDYBSE : 500124ISIN CODE : INE089A01023Industry : Pharmaceuticals & DrugsHouse : Dr. Reddy's
BSE5127.1513.1 (+0.26 %)
PREV CLOSE ( ) 5114.05
OPEN PRICE ( ) 5200.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 69577
TODAY'S LOW / HIGH ( )5090.70 5200.00
52 WK LOW / HIGH ( )2497.6 5514.65
NSE5129.8517.65 (+0.35 %)
PREV CLOSE( ) 5112.20
OPEN PRICE ( ) 5199.95
BID PRICE (QTY) 5129.85 (251)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2497630
TODAY'S LOW / HIGH( ) 5090.80 5200.00
52 WK LOW / HIGH ( )2495.05 5512.65
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 24-02 1984
Management Info
K Satish Reddy - Chairman GV Prasad - Managing Director
Registered Office

Address 8-2-337,Road No. 3,Banjara Hills,
Hyderabad,
Telangana-500034

Phone 040 - 4900 2900

Email sureshvs@drreddys.com ; shares@drreddys.com

Website www.drreddys.com

Registrars Details
Bigshare Services Pvt Ltd
306, Right Wing, Amrutha Ville, Opp. Yasodha Hospital,Raj Bhavan Road,Somajiguda,Hyderabad
Listing : BSE, NSE, MCX, New York
NEWS
28Sep Dr. Reddy’s, Indoco Remedies and Relia
Dr. Reddy’s Laboratories has launched Dimethyl Fumarate Delayed-Release..
28Sep Dr. Reddy's launches Dimethyl Fumarate
Dr. Reddy’s Laboratories has launched Dimethyl Fumarate Delayed-Release..
28Sep Dr. Reddy's rises on launching Dimethy
Dr. Reddys Laboratories is currently trading at Rs. 5165.95, up by 51.90..
25Sep Dr. Reddy's launches Dexmedetomidine H
Dr. Reddy's Laboratories has launched Dexmedetomidine Hydrochloride in 0..
25Sep Dr. Reddy's surges on launching Dexmed
Dr. Reddys Laboratories is currently trading at Rs. 5118.05, up by 93.60..
Financials
Rs. in Millions
QTR Jun 20 ANNUAL 20
Net Profit950229377
Gross Profit 13617 27758
Operating Profit 1573436128
Net Sales 32444118504
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Valiant Organics (BSE)
 2982.20 (6.70%)
M.Cap (Rs. in Cr)3623.14
Laurus Labs (BSE)
 1459.80 (10.00%)
M.Cap (Rs. in Cr)15648.91
Procter&Gamble Healt (BSE)
 5017.55 (2.66%)
M.Cap (Rs. in Cr)8328.82
Abbott India (BSE)
 16321.70 (0.71%)
M.Cap (Rs. in Cr)34682.47
Astrazeneca Pharma I (BSE)
 4403.70 (2.40%)
M.Cap (Rs. in Cr)11009.25
Shareholding Pattern
PROMOTERS 26.74%
NON-INSTITUTION 15.25%
MUTUAL FUNDS/UTI 9.96%
FI/BANKS/INSURANCE 4.53%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
Download Client Registration Documents (Rights & Obligations, Risk Disclosure Document, Do’s & Don’t’s) in Vernacular Language :
REGISTRATION NOS.

NSE CM-INZ000234235|NSE F& O - INZ000234235, NSE CD-INZ000234235, BSE CM–INZ000234235 |BSE F & O - INZ000234235|BSE CD- INZ000234235 MCX-SX CM-INZ000234235|MCX-SX F & O - INZ000234235|MCX-SX CD-INZ000234235 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912,CDSL : IN-DP-242-2016

INVESTOR PROTECTION

Compliance officer : Sanjay Jadli, Apurva Mittal, Tel No: 022-40790035,022-40790024, Mobile No: 9152943075,9768009000, E-mail ID: compliance@nnmsecurities.com,cdsl@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Filing complaints on SCORES Easy & quick

  • > Register on SCORES portal
  • > Mandatory details for filing complaints on SCORES
    • Name
    • PAN
    • Address
    • Mobile Number
    • E-mail ID
  • > Benefits:
    • Effective communication
    • Speedy redressal of the grievances

For Lodge the grievances click on https://scores.gov.in

Click/visit on SEBI Complaints Redress System (SCORES) for Procedure for filing of complaints on SCORES and benefits.

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.